Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2026 11:23 ET | Source: King Faisal Specialist Hospital & Research Centre

KFSH Scales Genomic Medicine from Research to Clinical Decision-Making

RIYADH, Saudi Arabia, April 24, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is advancing a clinically integrated model of genomic medicine, demonstrating how...
April 24, 2026 11:00 ET | Source: Indivior Pharmaceuticals Inc.

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder

A collaboration with Virginia Tech supports recognizing remission as a treatment outcome—capturing symptoms, quality of life, and functional outcomes—beyond abstinence aloneOf all MOUD, monthly...
April 24, 2026 10:43 ET | Source: A.D.A.M. Innovations

DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration
April 24, 2026 10:37 ET | Source: Medicana Health Group

Medicana Health Group Launches HPV Vaccination and Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups

Photo: Medicana Ataköy Hospital in Istanbul via FL Comms ISTANBUL, Türkiye, April 24, 2026 (GLOBE NEWSWIRE) -- Medicana Health Group has launched a new HPV vaccination and cervical cancer...
April 24, 2026 08:30 ET | Source: Gain Therapeutics, Inc.

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026

BETHESDA, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of...
April 24, 2026 08:00 ET | Source: Kyowa Kirin

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

TOKYO and SAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura Oncology, Inc. (Nasdaq: KURA, “Kura”) today announced the first patient has been...
April 24, 2026 07:38 ET | Source: Amphista Therapeutics

Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program

Cambridge, UK, 24th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the...
April 24, 2026 07:15 ET | Source: Dogecoin Cash, Inc.

Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification

DOGP highlights PrestoDoctor telehealth platform strategy following federal marijuana reclassification developments
April 24, 2026 04:00 ET | Source: Amphista Therapeutics

Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program

Cambridge, UK, 24th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the...
April 24, 2026 04:00 ET | Source: Levicept

Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis

SANDWICH, United Kingdom, April 24, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), will...